🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy dad had a heart attack and now I am terrified - will GLP-1 help? — looking for input Page 4

My dad had a heart attack and now I am terrified - will GLP-1 help? — looking for input

PharmHunterJen Thu, Jul 3, 2025 at 12:34 AM 37 replies 2,232 viewsPage 4 of 8
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jul 6, 2025 at 2:40 AM#16
pat_auckland said:
I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

Last edited: Jul 6, 2025 at 8:40 AM
41 16MikeFit_NJ, InsuranceTom, WendyG_ATL and 38 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Jul 6, 2025 at 12:23 PM#17
wendy_avl said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].

Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.

These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.

References:
[1] Hogan AE, et al. Diabetologia. 2014;57(4):781-784.
Last edited: Jul 6, 2025 at 6:23 PM
40 15JessicaM_2024, TomFromTexas, mike.trainer_LA and 37 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jul 6, 2025 at 10:06 PM#18
wendy_avl said:
I want to bring up the cardiovascular angle on cardiovascular risk.

6 month update on cardiovascular risk: down 51 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

39 14COA_Karl, MikeFit_NJ, InsuranceTom and 36 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Jul 7, 2025 at 7:49 AM#19

Following on from wendy_avl — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Jul 7, 2025 at 9:49 AM
38 13amy_econ_NJ, bbq_ray_KC, oliver_london and 35 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 7, 2025 at 5:32 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

16 16PurityPaulOR, MaxMetOK, MounjBrad and 13 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register